Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury
Clinical and Experimental Emergency Medicine
;
(4): 121-127, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-645332
ABSTRACT
Head injury is a common presenting complaint amongst emergency department patients. To date, there has been no widespread utilization of neuro-biomarkers to aid the diagnosis of traumatic brain injury. This review article explores which neuro-biomarkers could be used in the emergency department in aiding the clinical diagnosis of mild traumatic brain injury. Based on the available evidence, the most promising neuro-biomarkers appear to be Glial fibrillary acidic protein (GFAP) and Ubiquitin C-Terminal Hydrolase Isozyme L1 (UCH-L1) as these show significant rises in peripheral blood levels shortly after injury and these have been demonstrated to correlate with long-term clinical outcomes. Treatment strategies for minor traumatic brain injury in the emergency department setting are not well developed. The introduction of blood neuro-biomarkers could reduce unnecessary radiation exposure and provide an opportunity to improve the care of this patient group.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Conmoción Encefálica
/
Lesiones Encefálicas
/
Biomarcadores
/
Exposición a la Radiación
/
Ubiquitina Tiolesterasa
/
Diagnóstico
/
Servicio de Urgencia en Hospital
/
Proteína Ácida Fibrilar de la Glía
/
Traumatismos Craneocerebrales
Tipo de estudio:
Estudio diagnóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Clinical and Experimental Emergency Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS